BI-4020
CAS: 2664214-60-0
Ref. TM-T10534
1mg | 268.00 € | ||
5mg | 650.00 € | ||
10mg | 925.00 € | ||
25mg | 1,388.00 € | ||
50mg | 1,859.00 € | ||
1ml*10 (DMSO) | 790.00 € |
Product Information
- BI4020
BI-4020 is a fourth-generation, orally active, and non-covalent inhibitor of EGFR tyrosine kinase. BI-4020 exhibits activity agains the triple mutant EGFR del19 T790M C797S variant (IC50=0.2 nM in BaF3 cell lines), the double mutant EGFR del19 T790M and primary mutant EGFR del19 (IC50=1 nM) and EGFR wt (IC50=190 nM). BI-4020 exhibits high kinome selectivity and good DMPK properties.
Chemical properties
Technical inquiry about: TM-T10534 BI-4020
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.